BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

541 related articles for article (PubMed ID: 30482583)

  • 1. Exhaled-breath Testing for Prostate Cancer Based on Volatile Organic Compound Profiling Using an Electronic Nose Device (Aeonose™): A Preliminary Report.
    Waltman CG; Marcelissen TAT; van Roermund JGH
    Eur Urol Focus; 2020 Nov; 6(6):1220-1225. PubMed ID: 30482583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosing Non-Small Cell Lung Cancer by Exhaled Breath Profiling Using an Electronic Nose: A Multicenter Validation Study.
    Kort S; Brusse-Keizer M; Schouwink H; Citgez E; de Jongh FH; van Putten JWG; van den Borne B; Kastelijn EA; Stolz D; Schuurbiers M; van den Heuvel MM; van Geffen WH; van der Palen J
    Chest; 2023 Mar; 163(3):697-706. PubMed ID: 36243060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exhaled volatile organic compounds analysis by e-nose can detect idiopathic pulmonary fibrosis.
    Dragonieri S; Scioscia G; Quaranta VN; Carratu P; Venuti MP; Falcone M; Carpagnano GE; Foschino Barbaro MP; Resta O; Lacedonia D
    J Breath Res; 2020 Jul; 14(4):047101. PubMed ID: 32320958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detecting multiple sclerosis via breath analysis using an eNose, a pilot study.
    Ettema AR; Lenders MWPM; Vliegen J; Slettenaar A; Tjepkema-Cloostermans MC; de Vos CC
    J Breath Res; 2021 Jan; 15(2):. PubMed ID: 33271513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultrafast gas chromatography coupled to electronic nose to identify volatile biomarkers in exhaled breath from chronic obstructive pulmonary disease patients: A pilot study.
    Rodríguez-Aguilar M; Ramírez-García S; Ilizaliturri-Hernández C; Gómez-Gómez A; Van-Brussel E; Díaz-Barriga F; Medellín-Garibay S; Flores-Ramírez R
    Biomed Chromatogr; 2019 Dec; 33(12):e4684. PubMed ID: 31423612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feasibility of volatile organic compound in breath analysis in the follow-up of colorectal cancer: A pilot study.
    Steenhuis EGM; Schoenaker IJH; de Groot JWB; Fiebrich HB; de Graaf JC; Brohet RM; van Dijk JD; van Westreenen HL; Siersema PD; de Vos Tot Nederveen Cappel WH
    Eur J Surg Oncol; 2020 Nov; 46(11):2068-2073. PubMed ID: 32778485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of profiles of volatile organic compounds in exhaled breath by means of an electronic nose as a proposal for a screening method for breast cancer: a case-control study.
    Díaz de León-Martínez L; Rodríguez-Aguilar M; Gorocica-Rosete P; Domínguez-Reyes CA; Martínez-Bustos V; Tenorio-Torres JA; Ornelas-Rebolledo O; Cruz-Ramos JA; Balderas-Segura B; Flores-Ramírez R
    J Breath Res; 2020 Sep; 14(4):046009. PubMed ID: 32698165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evening and morning exhaled volatile compound patterns are different in obstructive sleep apnoea assessed with electronic nose.
    Kunos L; Bikov A; Lazar Z; Korosi BZ; Benedek P; Losonczy G; Horvath I
    Sleep Breath; 2015 Mar; 19(1):247-53. PubMed ID: 24840212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative analysis of volatile organic compounds of breath and urine for distinguishing patients with liver cirrhosis from healthy controls by using electronic nose and voltammetric electronic tongue.
    Zaim O; Diouf A; El Bari N; Lagdali N; Benelbarhdadi I; Ajana FZ; Llobet E; Bouchikhi B
    Anal Chim Acta; 2021 Nov; 1184():339028. PubMed ID: 34625262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multi-centre prospective study on diagnosing subtypes of lung cancer by exhaled-breath analysis.
    Kort S; Tiggeloven MM; Brusse-Keizer M; Gerritsen JW; Schouwink JH; Citgez E; de Jongh FHC; Samii S; van der Maten J; van den Bogart M; van der Palen J
    Lung Cancer; 2018 Nov; 125():223-229. PubMed ID: 30429025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An electronic nose in the discrimination of patients with non-small cell lung cancer and COPD.
    Dragonieri S; Annema JT; Schot R; van der Schee MP; Spanevello A; Carratú P; Resta O; Rabe KF; Sterk PJ
    Lung Cancer; 2009 May; 64(2):166-70. PubMed ID: 18834643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Data analysis of electronic nose technology in lung cancer: generating prediction models by means of Aethena.
    Kort S; Brusse-Keizer M; Gerritsen JW; van der Palen J
    J Breath Res; 2017 Jun; 11(2):026006. PubMed ID: 28373602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Noninvasive detection of soft tissue sarcoma using volatile organic compounds in exhaled breath: a pilot study.
    Acem I; van Praag VM; Mostert CQ; van der Wal RJ; Neijenhuis RM; Verhoef C; Grünhagen DJ; van de Sande MA
    Future Oncol; 2023 Mar; 19(10):697-704. PubMed ID: 37129048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of exhaled volatile organic compounds analysis using electronic nose as index of COPD severity.
    Finamore P; Pedone C; Scarlata S; Di Paolo A; Grasso S; Santonico M; Pennazza G; Antonelli Incalzi R
    Int J Chron Obstruct Pulmon Dis; 2018; 13():1441-1448. PubMed ID: 29750030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pilot Study: Detection of Gastric Cancer From Exhaled Air Analyzed With an Electronic Nose in Chinese Patients.
    Schuermans VNE; Li Z; Jongen ACHM; Wu Z; Shi J; Ji J; Bouvy ND
    Surg Innov; 2018 Oct; 25(5):429-434. PubMed ID: 29909757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electronic nose technology for detection of invasive pulmonary aspergillosis in prolonged chemotherapy-induced neutropenia: a proof-of-principle study.
    de Heer K; van der Schee MP; Zwinderman K; van den Berk IA; Visser CE; van Oers R; Sterk PJ
    J Clin Microbiol; 2013 May; 51(5):1490-5. PubMed ID: 23467602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of differentiated thyroid carcinoma in exhaled breath with an electronic nose.
    Scheepers MHMC; Al-Difaie ZJJ; Wintjens AGWE; Engelen SME; Havekes B; Lubbers T; Coolsen MME; van der Palen J; van Ginhoven TM; Vriens M; Bouvy ND
    J Breath Res; 2022 Jun; 16(3):. PubMed ID: 35688135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breathing Rhythm Variations during Wash-In Do Not Influence Exhaled Volatile Organic Compound Profile Analyzed by an Electronic Nose.
    Dragonieri S; Quaranta VN; Carratù P; Ranieri T; Buonamico E; Carpagnano GE
    Molecules; 2021 May; 26(9):. PubMed ID: 34064506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. VOC-based detection of prostate cancer using an electronic nose and ion mobility spectrometry: A novel urine-based approach.
    Heers H; Chwilka O; Huber J; Vogelmeier C; Koczulla AR; Baumbach JI; Boeselt T
    Prostate; 2024 Jun; 84(8):756-762. PubMed ID: 38497426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expiratory flow rate, breath hold and anatomic dead space influence electronic nose ability to detect lung cancer.
    Bikov A; Hernadi M; Korosi BZ; Kunos L; Zsamboki G; Sutto Z; Tarnoki AD; Tarnoki DL; Losonczy G; Horvath I
    BMC Pulm Med; 2014 Dec; 14():202. PubMed ID: 25510554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.